Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2016
France's High Authority of Health is in favour of delisting Alzheimer's disease drugs
22 October 2016 - The Transparency Committee, responsible for evaluating medicinal products within the High Authority of Health recommended against ...